Advertisement

Topics

Researchers streamline beta cell differentiation process to develop safer cell therapy for diabetes

05:20 EDT 1 Aug 2017 | News-Medical.net

More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune system resulting in deficient insulin production that requires daily blood glucose monitoring and administration of insulin.

Original Article: Researchers streamline beta cell differentiation process to develop safer cell therapy for diabetes

NEXT ARTICLE

More From BioPortfolio on "Researchers streamline beta cell differentiation process to develop safer cell therapy for diabetes"

Quick Search
Advertisement
 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...